1887

Abstract

Recently, three distinct genotypes (1, 2 and 3) of human parvovirus B19 (B19) have been identified. However, the characteristics and distribution of B19 genotypes in Vietnam have not been investigated. Phylogenetic analysis using 49 subgenomic NS1/VP1u regions and two coding NS1–VP1/VP2 regions has been applied to investigate the prevalence of B19 genotypes in Vietnamese patients co-infected with . Genetic analysis of the subgenomic NS1/VP1u region of B19 revealed that two genotypes of B19 were identified in these populations, with predominance of genotype 1 (47/49, 96 %) followed by genotype 2 (2/49, 4 %), but not genotype 3. Further, phylogenetic analysis of subgenomic B19 genomes revealed two major subgroups within genotype 1 (B19-1A and B19-1B) with an estimated nucleotide difference of >5 % between each subgroup, forming different branches. The mean percentage of amino acid variation between subgroup B19-1A and B19-1B was >2 % of the NS1, VP1 and VP2 proteins. Our results indicated that two of the three known genotypes of B19 were present in Vietnamese patients, with genotype 1 predominating, and that this genotype can be classified into at least two subgroups, B19-1A and B19-1B.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82037-0
2006-10-01
2021-02-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/10/2941.html?itemId=/content/journal/jgv/10.1099/vir.0.82037-0&mimeType=html&fmt=ahah

References

  1. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L. R., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet i, 1378
    [Google Scholar]
  2. Barah F., Vallely P. J., Chiswick M. L., Cleator G. M., Kerr J. R. 2001; Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 358:729–730 [CrossRef]
    [Google Scholar]
  3. Bergoin M., Tijssen P. 1998; Biological and molecular properties of densoviruses and their use in protein expression and biological control. In The Insect Viruses pp  141–169 Edited by Miller L. K., Ball L. A. New York: Plenum;
    [Google Scholar]
  4. Bock C.-T. 2006; Parvovirus B19: a new emerging pathogenic agent of inflammatory cardiomyopathy. Ernst Schering Res Found Workshop 55:83–97
    [Google Scholar]
  5. Bock C.-T., Klingel K., Aberle S., Duechting A., Lupescu A., Lang F., Kandolf R. 2005; Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy. J Vet Med B Infect Dis Vet Public Health 52:340–343 [CrossRef]
    [Google Scholar]
  6. Bültmann B. D., Klingel K., Sotlar K., Bock C. T., Baba H. A., Sauter M., Kandolf R. 2003; Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92–95 [CrossRef]
    [Google Scholar]
  7. Candotti D., Etiz N., Parsyan A., Allain J.-P. 2004; Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78:12169–12178 [CrossRef]
    [Google Scholar]
  8. Cotmore S. F., McKie V. C., Anderson L. J., Astell C. R., Tattersall P. 1986; Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60:548–557
    [Google Scholar]
  9. Dingli D., Pfizenmaier D. H., Arromdee E., Wennberg P., Spittell P. C., Chang-Miller A., Clarke B. L. 2000; Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 356:312–314
    [Google Scholar]
  10. Dorsch S., Liebisch G., Kaufmann B., von Landenberg P., Hoffmann J. H., Drobnik W., Modrow S. 2002; The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76:2014–2018 [CrossRef]
    [Google Scholar]
  11. Erdman D. D., Durigon E. L., Wang Q.-Y., Anderson L. J. 1996; Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates. J Gen Virol 77:2767–2774 [CrossRef]
    [Google Scholar]
  12. Finkel T. H., Török T. J., Ferguson P. J. & 8 other authors 1994; Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?. Lancet 343:1255–1258 [CrossRef]
    [Google Scholar]
  13. Fukada K., Matumoto K., Takakura F., Yamaki M., Sato H., Okochi K., Maeda Y. 2000; Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein. J Med Virol 62:60–69 [CrossRef]
    [Google Scholar]
  14. Gallinella G., Venturoli S., Manaresi E., Musiani M., Zerbini M. 2003; B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 28:1–13 [CrossRef]
    [Google Scholar]
  15. He Z., Zhuang H., Wang X., Song S., Dong Q., Yan J., Buehring G. C., Luo G. 2003; Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection. J Med Virol 69:59–65 [CrossRef]
    [Google Scholar]
  16. Heegaard E. D., Brown K. E. 2002; Human parvovirus B19. Clin Microbiol Rev 15:485–505 [CrossRef]
    [Google Scholar]
  17. Hemauer A., von Poblotzki A., Gigler A., Cassinotti P., Siegl G., Wolf H., Modrow S. 1996; Sequence variability among different parvovirus B19 isolates. J Gen Virol 77:1781–1785 [CrossRef]
    [Google Scholar]
  18. Hillingsø J. G., Jensen I. P., Tom-Petersen L. 1998; Parvovirus B19 and acute hepatitis in adults. Lancet 351:955–956 [CrossRef]
    [Google Scholar]
  19. Hokynar K. M., Söderlund-Venermo M., Pesonen M., Ranki A., Kiviluoto O., Partio E. K., Hedman K. 2002; A new parvovirus genotype persistent in human skin. Virology 302:224–228 [CrossRef]
    [Google Scholar]
  20. Karetnyi Y. V., Beck P. R., Markin R. S., Langnas A. N., Naides S. J. 1999; Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144:1713–1724 [CrossRef]
    [Google Scholar]
  21. Kimura M. 1980; A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120 [CrossRef]
    [Google Scholar]
  22. Liefeldt L., Plentz A., Klempa B., Kershaw O., Endres A.-S., Raab U., Neumayer H.-H., Meisel H., Modrow S. 2005; Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75:161–169 [CrossRef]
    [Google Scholar]
  23. Moore T. L. 2000; Parvovirus-associated arthritis. Curr Opin Rheumatol 12:289–294 [CrossRef]
    [Google Scholar]
  24. Morinet F. 1992; Parvovirus B19 infection. Pathol Biol 40:621–622 (in French
    [Google Scholar]
  25. Naides S. J., Karetnyi Y. V., Cooling L. L. W. & 7 other authors 1996; Human parvovirus B19 infection and hepatitis. Lancet 347:1563–1564 [CrossRef]
    [Google Scholar]
  26. Nguyen Q. T., Wong S., Heegaard E. D., Brown K. E. 2002; Identification and characterization of a second novel human erythrovirus variant. A6 Virology 301374–380 [CrossRef]
  27. Saitou N., Nei M. 1987; The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425
    [Google Scholar]
  28. Sanabani S., Neto W. K., Pereira J., Sabino E. C. 2006; Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 44:604–606 [CrossRef]
    [Google Scholar]
  29. Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J. F., Garbarg-Chenon A. 2002; Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76:9124–9134 [CrossRef]
    [Google Scholar]
  30. Song L. H., Binh V. Q., Duy D. N., Kun J. F. J., Bock C. T., Kremsner P. G., Luty A. J. F. 2003; Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28:93–103 [CrossRef]
    [Google Scholar]
  31. Song L. H., Binh V. Q., Duy D. N., Bock T. C., Kremsner P. G., Luty A. J. F., Mavoungou E. 2004; Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus. J Med Virol 73:244–249 [CrossRef]
    [Google Scholar]
  32. Sukhumsirichart W., Attasart P., Boonsaeng V., Panyim S. 2006; Complete nucleotide sequence and genomic organization of hepatopancreatic parvovirus (HPV) of Penaeus monodon . Virology 346:266–277 [CrossRef]
    [Google Scholar]
  33. Takahashi Y., Murai C., Shibata S. & 7 other authors 1998; Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A 95:8227–8232 [CrossRef]
    [Google Scholar]
  34. Thompson J. D., Higgins D. G., Gibson T. J. 1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680 [CrossRef]
    [Google Scholar]
  35. Toan N. L., Song L. H., Kremsner P. G. & 7 other authors 2006; Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol (in press). doi: 10.1016/j.jhep.2006.03.013
    [Google Scholar]
  36. Tschöpe C., Bock C.-T., Kasner M. & 8 other authors 2005; High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111:879–886 [CrossRef]
    [Google Scholar]
  37. Walker S. L., Wonderling R. S., Owens R. A. 1997; Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity. J Virol 71:2722–2730
    [Google Scholar]
  38. Yoto Y., Kudoh T., Haseyama K., Suzuki N., Chiba S. 1996; Human parvovirus B19 infection associated with acute hepatitis. Lancet 347:868–869 [CrossRef]
    [Google Scholar]
  39. Young N. S., Brown K. E. 2004; Parvovirus B19. N Engl J Med 350:586–597 [CrossRef]
    [Google Scholar]
  40. Zhi N., Zádori Z., Brown K. E., Tijssen P. 2004; Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318:142–152 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82037-0
Loading
/content/journal/jgv/10.1099/vir.0.82037-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error